Home Add to Favorite Contact Submit  
           19 August, 2018


    
Category:  Press » Nanotechnology

 

AngelMD Venture Capital Fund Invests in Leading Bone Biologic Startup

Popularity:
         Views: 540
2018-01-07 07:17:35     
Angelmd.co/en

SEATTLE - January 04, 2018 -- Today, AngelMD’s Catalyst I LP announced it has invested in Artoss, Inc. Artoss is a bone biologic company focused on improving bone grafting technology through a combination of nanotechnology and biology. This is AngelMD's second investment into the company, following a combined syndicate round in Q1 of 2016.

With traditional bone grafts, there are numerous risks, including rejection of the grafting material and infection of donated bone. As noted by the National Center for Biotechnology Information, grafting success is further complicated due to unacceptable processing techniques that can destroy the structure and osteoinductive capacities of the graft material.

More recent advancements in the field have relied on novel graft materials, such as the NanoBone technology from Artoss. NanoBone improves on existing processes by using nanocrystals of hydroxyapatite (the chief structural element of naturally-occurring bone) that are suspended in a silica gel matrix. These crystals closely mimic the hydroxyapatite found in human bone, and they are 100,000 times smaller than the bioceramic particles found in other grafting treatments. Their smaller size leads to higher rates of acceptance, and better end results for the patient.

NanoBone has proven to be clinically effective in Europe, where the company has operated for over ten years. Artoss is now bringing the full line of NanoBone products to the United States, after being granted FDA 510(k) approval. Further, the company's products have recently been approved for purchase by the United States Department of Defense, under a Defense Acquisition Purchasing Agreement with the Prime Vendor, Owens & Minor.

Most recently, Artoss announced its NanoBone QD Bone Graft product, allowing for quick delivery of the NanoBone SBX Putty via an applicator that facilitates controlled and precise use in a cost-effective system. The product will be on display during the North American Spine Society NASS 2017 Conference in Orlando, from October 25th through the 28th.

Charlie Emley, Managing Partner of the Catalyst I Fund initially joins the Artoss Board of Directors as a Board Observer, lending his extensive management and investing expertise to support the Artoss, Inc. management team.

“As revenue continues to grow, and visibility and interest from industry rises, we felt like this was an ideal time to add support to the company as they drive to the next level. I am looking forward to working with the founders and their German partners, all of whom are seasoned veterans with a track record of success,” said Charlie Emley.

“The contacts, feedback and capital we have received from the AngelMD community have helped us achieve some very early wins. With the debut of our new NanoBone QD Bone Graft at the North American Spine Society meeting this week, capital from their Catalyst venture fund, and the expertise of Charlie Emley, we are really poised for a successful 2018.” said James Cassidy, PhD, Artoss, Inc. Co-Founder.

About AngelMD
AngelMD is an investment and networking platform connecting innovative medical startups, physicians, investors, and industry partners. Leading physicians from all over the US have joined AngelMD to help source, evaluate and advise companies in biotechnology, medical device, and healthcare technology.

About Artoss, Inc.
Artoss, Inc. is a leading bone biologic company, focused on NanoBiology. Applied NanoBiology is the intersection between nanotechnology and biology. Artoss scientists apply their knowledge of physics and biology to create new nanostructured biomaterials for bone repair.

Specialized in: Biologic Company
URL: https://www.angelmd.co/en
Print press release      Bookmark this page
Related Press releases 
IBM Breakthrough Captures High Speed Measurements of Individual Atoms (Popularity: ): Today IBM (NYSE: IBM) researchers published a breakthrough technique in the peer-reviewed journal Science that measures how long a single atom can hold information, and giving scientists the ability to record, study and "visualize" extremely fast phenomena inside these atoms. Just as the first motion pictures conveyed movement through high-speed photography, scientists at IBM Research – Almaden are using the Scanning Tunneling Microscope like a high-speed camera to record the ...
Bacteria Pervasively Contaminating Chinese Drywall Conclusively Identified (Popularity: ): RealTime Laboratories, LLC announced today significant new findings regarding pervasive bacterial presence unique to contaminated drywall. RealTime has identified specific bacteria found only in symptomatic drywall and not in normal domestic drywall that are viable, pervasive and produce hydrogen sulfide and reduced sulfur gases under conditions similar to those found in residences. Cultures developed by RealTime using symptomatic contaminated drywall demonstrated a bacterial mat formation, generated copious amounts of hydrogen ...
IBM Scientists First to Image the 'Anatomy' of a Molecule (Popularity: ): IBM (NYSE: IBM) scientists have been able to image the "anatomy" -- or chemical structure -- inside a molecule with unprecedented resolution, using a complex technique known as noncontact atomic force microscopy.The results push the exploration of using molecules and atoms at the smallest scale and could greatly impact the field of nanotechnology, which seeks to understand and control some of the smallest objects known to mankind."Though not an exact ...
Ecology Coatings Hosts Conference Call to Discuss Third Quarter Financial Results and Provide Shareholder Update (Popularity: ): Ecology Coatings, Inc. (OTC Bulletin Board: ECOC), a leader in the discovery and development of nanotechnology-enabled, ultraviolet-curable advanced coatings, today announced that it will hold a conference call to provide a shareholder update on Thursday, August 27, 2009, at 11:00 a.m. Eastern Daylight Time. Shareholders and members of the investment community are invited to participate in the conference call. In addition to providing a corporate update, Ecology Coatings' management team ...
Frost & Sullivan Lauds Organic Spintronics' Active R&D Efforts that Have Placed it at the Forefront of Spintronics-Based Innovation for Sensing Applications (Popularity: ): Based on its recent analysis of the spintronics markets for sensor applications, Frost & Sullivan recognizes Organic Spintronics with the 2008 European Frost & Sullivan Technology Innovation Award for its discovery of organic spintronics by combining organic semiconductors with ferromagnetic materials.Most of the research in spintronics is centred on the use of inorganic semiconductors such as gallium arsenide, which are not suitable for room temperature operations. Organic Spintronics innovatively used ...

Press release home snapshot 


Related Business 
MedSciences Capital (Popularity: ): Focus: independent venture capital fund that exclusively invests in early stage human life sciences companies.
ProSeed Venture Capital Fund (Popularity: ): An Israeli, public, non-listed venture capital fund investing in start-up companies.
Startup Report (Popularity: ): If you are an entrepreneur seeking angel or venture capital funding for your business the Startup Report can help.
Sicom Venture Capital (Popularity: ): Focus: invests in early stage intellectual property based companies.
Momentum Venture Capital (Popularity: ): Invests in a broad range of high-tech, early stage Australian businesses.
Summer Street Capital Partners (Popularity: ): Focus: private equity fund, venture capital, investment, financing.
Mitiska Net Fund Europe (Popularity: ): European Internet venture capital fund, based in Belgium. Company profile, team members, portfolio and news.
Venture Capital Investing Conference (Popularity: ): Venture Capital Investing Conference is the Premier Industry Gathering for institutional investors and venture capitalists. Over Two Decades of Convening the Venture Capital Investing Community, this summit is consistently regarded as the most important gathering of its kind, uniting hundreds of venture firms ? those who pave the way for the expanded path of the industry.
First Stage Capital (Popularity: ): UK network of business angels, incubators, and venture capital investors that helps entrepreneurs fund technology start-ups.
Fulcrum Investments (Popularity: ): Focus: private early stage venture fund providing seed and first round financing for socially responsible startup and emerging companies.